Dr Reddy’s gets Brazil approval for generic semaglutide injection
Dr Reddy’s Laboratories has received marketing authorisation from Brazil’s ANVISA for its generic semaglutide injection, the company said on 5 November. The drug, a generic version of Novo Nordisk’s Ozempic, will be…
Ashin Xavier: interesting
IO Repro: Repro test v4 after fix 2 Oct. Safe to trash.
IO Repro: Repro test v3 after fix 2 Oct. Safe to trash.
IO Repro: Repro test after fix 2 Oct. Safe to trash.